Skip to main content

Table 1 Results of high-resolution SNP Microarray

From: Bi-allelic amplification of ATM gene in blastoid variant of mantle cell lymphoma: a novel mechanism of inactivation due to chromoanagenesis?

Chr

CNV

Cytoband start

Cytoband end

Genomic position start–end GRCh37

Size (Mb)

CN state

3

Gain

q13.11

q29

104,275,677–197,851,986

93.6

3

3

GainMosaic

q13.11

q29

104,347,395–197,851,986

93.5

3

4

LossMosaic

q13.1

q13.2

62,098,409–68,284,650

6.2

2

7

Gain

p22.3

p22.1

43,360–6,055,929

6.0

4

7

Gain

q21.13

q22.1

9,1027,069–100,918,485

9.9

3

7

Loss

p22.1

p21.3

7,263,512–12,522,467

5.3

1

7

Loss

p21.3

p14.1

13,107,394–37,647,617

24.5

1

7

Loss

q31.2

q36.3

116,762,426–159,119,707

42.4

1

7

GainMosaic

p14.2

p14.1

36,647,816–40,257,749

3.6

3

7

GainMosaic

q21.11

q22.1

85,370,550–103,219,749

17.9

3

7

LossMosaic

p21.3

p14.3

9,301,862–33,690,301

24.4

1

7

LossMosaic

q31.31

q36.3

117,402,248–159,119,707

41.7

1

9

Loss

p24.2

p13.2

2,582,103–38,044,560

35.5

1

9

LossMosaic

p24.2

p13.2

2,765,255–38,317,590

35.6

1

11

Gain

p15.5

p12

1,806,954–36,471,669

34.7

3

11

Gain

q13.4

q21

74,900,610–9,6287,065

21.4

3

11

Gain

q21

q22.2

96,439,368–102,413,943

6.0

3

11

Gain

q22.2

q22.3

102,414,120–108,729,175

6.3

4

11

Gain

q22.3

q23.1

109,718,291–111,689,133

2.0

4

11

Loss

q22.3

q22.3

108,729,392–109,715,602

9.9

1

11

Loss

q23.1

q25

111,731,307–134,788,683

23.1

1

11

GainMosaic

p15.5

p12

230,615–36,614,253

36.4

3

11

LossMosaic

q23.3

q25

114,847,579–134,938,470

20.1

1

13

Loss

q32.1

q34

95,258,943–114,609,241

19.4

1

13

LossMosaic

q12.3

q21.2

31,921,726–62,123,665

30.2

2

13

LossMosaic

q32.1

q34

96,138,381–115,107,733

19.0

1

14

Gain

q32.33

q32.33

106,072,250–106,692,891

0.6

3

17

Loss

p13.3

p11.2

525–21,565,553

21.6

1

17

LossMosaic

p13.3

p11.2

525–20,007,075

20.0

1

19

Gain

q13.12

q13.43

37,805,520–58,813,857

21.0

3

19

GainMosaic

q13.12

q13.43

37,516,085–58,956,888

21.4

3

X

Loss

p22.33

p21.3

2,693,466–25,047,578

22.4

1

X

Loss

p21.3

q23

25,048,192–115,589,080

90.5

1

X

Loss

q23

q24

115,592,089–118,552,562

3.0

1

X

Loss

q24

q28

118,552,991–155,059,506

36.5

1

Y

Gain

p11.31

q11.23

2,660,575–28,799,937

26.1

1